Programming of Maternal and Offspring Disease: Impact of Growth Restriction, Fetal Sex and Transmission Across Generations
Overview
Affiliations
Babies born small are at an increased risk of developing myriad adult diseases. While growth restriction increases disease risk in all individuals, often a second hit is required to unmask 'programmed' impairments in physiology. Programmed disease outcomes are demonstrated more commonly in male offspring compared with females, with these sex-specific outcomes partly attributed to different placenta-regulated growth strategies of the male and female fetus. Pregnancy is known to be a major risk factor for unmasking a number of conditions and can be considered a 'second hit' for women who were born small. As such, female offspring often develop impairments of physiology for the first time during pregnancy that present as pregnancy complications. Numerous maternal stressors can further increase the risk of developing a maternal complication during pregnancy. Importantly, these maternal complications can have long-term consequences for both the mother after pregnancy and the developing fetus. Conditions such as preeclampsia, gestational diabetes and hypertension as well as thyroid, liver and kidney diseases are all conditions that can complicate pregnancy and have long-term consequences for maternal and offspring health. Babies born to mothers who develop these conditions are often at a greater risk of developing disease in adulthood. This has implications as a mechanism for transmission of disease across generations. In this review, we discuss the evidence surrounding long-term intergenerational implications of being born small and/or experiencing stress during pregnancy on programming outcomes.
The Role of Placental MFF-Mediated Mitochondrial Fission in Gestational Diabetes Mellitus.
Wei L, Fang C, Jiang Y, Zhang H, Gao P, Zhou X Diabetes Metab Syndr Obes. 2025; 18:541-554.
PMID: 39995822 PMC: 11849531. DOI: 10.2147/DMSO.S484002.
Analysis of the evolution of placental oxidative stress research from a bibliometric perspective.
Chen A, Tian M, Luo Z, Cao X, Gu Y Front Pharmacol. 2024; 15:1475244.
PMID: 39484166 PMC: 11524950. DOI: 10.3389/fphar.2024.1475244.
DNA methylation landscape in pregnancy-induced hypertension: progress and challenges.
Deng F, Lei J, Qiu J, Zhao C, Wang X, Li M Reprod Biol Endocrinol. 2024; 22(1):77.
PMID: 38978060 PMC: 11229300. DOI: 10.1186/s12958-024-01248-0.
Ngema M, Xulu N, Ngubane P, Khathi A Biomedicines. 2024; 12(6).
PMID: 38927579 PMC: 11201628. DOI: 10.3390/biomedicines12061372.
Svigkou A, Katsi V, Kordalis V, Tsioufis K Int J Mol Sci. 2024; 25(10).
PMID: 38791492 PMC: 11121482. DOI: 10.3390/ijms25105455.